Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Roche Hldg Ltd Spons (RHHBY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 219,456,528
  • Shares Outstanding, K 6,815,420
  • Annual Sales, $ 53,441 M
  • Annual Income, $ 9,723 M
  • 36-Month Beta 0.63
  • Price/Sales 4.39
  • Price/Cash Flow 17.76
  • Price/Book 8.13
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/01/17
  • Annual Dividend & Yield 0.85 (2.65%)
  • Most Recent Dividend 0.84 on 03/15/17
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.7000 +5.11%
on 07/11/17
32.8200 -1.68%
on 06/28/17
-0.3300 (-1.01%)
since 06/21/17
3-Month
30.7000 +5.11%
on 07/11/17
36.8200 -12.36%
on 04/28/17
+0.6700 (+2.12%)
since 04/21/17
52-Week
25.2500 +27.80%
on 12/08/16
36.8200 -12.36%
on 04/28/17
+0.7100 (+2.25%)
since 07/21/16

Most Recent Stories

More News
Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?

ImmunoGen has made significant progress with its ovarian cancer pipeline candidate. Let's see if the company can come up with a beat this earnings season.

EXAS : 39.17 (+0.33%)
IMGN : 5.66 (-4.07%)
NVLS : 2.35 (-1.67%)
RHHBY : 32.2700 (+0.22%)
SHAREHOLDER REMINDER: Khang & Khang LLP Announces Securities Class Action Lawsuit against Roche Holding AG and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 19, 2017 / Khang & Khang LLP (the ''Firm'') announces a securities class action lawsuit against Roche Holding AG (''Roche Holding'' or the ''Company'') (OTCQX: RHHBY). Investors...

RHHBY : 32.2700 (+0.22%)
Puma's (PBYI) Breast Cancer Drug Neratinib Gets FDA Approval

Puma Biotechnology, Inc's (PBYI) lead breast cancer candidate neratinib is approved by FDA and is set to be commercially available in September under the brand name, Nerlynx.

PBYI : 94.30 (-0.47%)
NVS : 84.99 (-0.50%)
RHHBY : 32.2700 (+0.22%)
GSK : 42.66 (-0.26%)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Roche Holding AG and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 18, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Roche Holding AG ("Roche" or the "Company") (OTCQX: RHHBY) for possible...

RHHBY : 32.2700 (+0.22%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Roche Holding AG. (RHHBY) and Lead Plaintiff Deadline: August 7, 2017

NEW YORK, NY / ACCESSWIRE / July 18, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Roche Holding AG. ("Roche" or the "Company") (OTCQX:...

RHHBY : 32.2700 (+0.22%)
Novartis Tops Q2 Earnings, Sandoz Faces Pricing Pressure

Novartis AG (NVS) reported second-quarter 2017 core earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 but the recorded figure was a penny lower than the year-ago figure of $1.23....

JNJ : 135.31 (-0.92%)
NVS : 84.99 (-0.50%)
RHHBY : 32.2700 (+0.22%)
AMGN : 180.21 (+0.50%)
The Zacks Analyst Blog Highlights: Infosys, Toyota Motor, Honda Motor, Taiwan Semiconductor Manufacturing and Roche Holdings

The Zacks Analyst Blog Highlights: Infosys, Toyota Motor, Honda Motor, Taiwan Semiconductor Manufacturing and Roche Holdings

TM : 109.31 (-0.48%)
INFY : 15.68 (+1.03%)
RHHBY : 32.2700 (+0.22%)
HMC : 27.52 (-0.65%)
TSM : 35.85 (-0.69%)
AstraZeneca (AZN) CEO Rumor Reportedly Ends, Shares Rise

AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA).

AZN : 34.05 (+0.47%)
TEVA : 32.64 (+0.65%)
RHHBY : 32.2700 (+0.22%)
SNY : 47.71 (-0.73%)
Foreign Stock Roundup: Infosys Beats, Taiwan Semiconductor Misses

Dovish comments from Yellen helped global stocks post gains.

PBR : 8.48 (-2.42%)
TM : 109.31 (-0.48%)
INFY : 15.68 (+1.03%)
RHHBY : 32.2700 (+0.22%)
VALE : 9.02 (-1.20%)
SNY : 47.71 (-0.73%)
HMC : 27.52 (-0.65%)
TSM : 35.85 (-0.69%)
UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Roche Holding AG and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 17, 2017 / Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Roche Holding AG ("Roche Holding" or the "Company") (OTCQX: RHHBY). Investors,...

RHHBY : 32.2700 (+0.22%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More

Support & Resistance

2nd Resistance Point 32.4367
1st Resistance Point 32.3533
Last Price 32.2700
1st Support Level 32.1133
2nd Support Level 31.9567

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.